thalidomide has been researched along with Angiomatosis in 3 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Angiomatosis: A condition with multiple tumor-like lesions caused either by congenital or developmental malformations of BLOOD VESSELS, or reactive vascular proliferations, such as in bacillary angiomatosis. Angiomatosis is considered non-neoplastic.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thalidomide 100 mg/day stabilized multiple angiomatosis better than interferon alfa." | 7.78 | [Chronic disseminated intravascular coagulation (DIC) markers in a patient with multiple angiomatosis during treatment with anti-angiogenics: interferon α, thalidomide and lenalidomide]. ( Adam, Z; Hájek, R; Koukalová, R; Král, Z; Krejčí, M; Křikavová, L; Matýšková, M; Mayer, J; Navrátil, M; Nebeský, T; Neuman, C; Pour, L; Rehák, Z; Szturz, P; Tomíška, M, 2012) |
| "Multiple angiomatosis is a very rare disease formed by histologically benign angiomas spreading beyond single organ or tissue." | 5.35 | [Treatment of multiple angiomatosis involving the skeleton and the abdominal and thoracic cavities with interferon alpha, thalidomide and zoledronate]. ( Adam, Z; Krejcí, M; Krikavová, L; Mechl, M; Moulis, M; Navrátil, M; Neumann, C; Pour, L; Vanícek, J; Veselý, K; Vorlícek, J, 2008) |
| "Thalidomide 100 mg/day stabilized multiple angiomatosis better than interferon alfa." | 3.78 | [Chronic disseminated intravascular coagulation (DIC) markers in a patient with multiple angiomatosis during treatment with anti-angiogenics: interferon α, thalidomide and lenalidomide]. ( Adam, Z; Hájek, R; Koukalová, R; Král, Z; Krejčí, M; Křikavová, L; Matýšková, M; Mayer, J; Navrátil, M; Nebeský, T; Neuman, C; Pour, L; Rehák, Z; Szturz, P; Tomíška, M, 2012) |
| "Multiple angiomatosis is a very rare disease formed by histologically benign angiomas spreading beyond single organ or tissue." | 1.35 | [Treatment of multiple angiomatosis involving the skeleton and the abdominal and thoracic cavities with interferon alpha, thalidomide and zoledronate]. ( Adam, Z; Krejcí, M; Krikavová, L; Mechl, M; Moulis, M; Navrátil, M; Neumann, C; Pour, L; Vanícek, J; Veselý, K; Vorlícek, J, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adam, Z | 3 |
| Krikavová, L | 2 |
| Krejcí, M | 3 |
| Mechl, M | 2 |
| Pour, L | 3 |
| Moulis, M | 1 |
| Vanícek, J | 1 |
| Neumann, C | 1 |
| Navrátil, M | 3 |
| Veselý, K | 1 |
| Vorlícek, J | 1 |
| Pourová, E | 1 |
| Synek, O | 1 |
| Zahradová, L | 1 |
| Nebeský, T | 2 |
| Neubauer, J | 1 |
| Feit, J | 1 |
| Vokurková, J | 1 |
| Král, Z | 2 |
| Bednarík, O | 1 |
| Slampa, P | 1 |
| Dolezalová, H | 1 |
| Hájek, R | 2 |
| Mayer, J | 2 |
| Matýšková, M | 1 |
| Tomíška, M | 1 |
| Szturz, P | 1 |
| Rehák, Z | 1 |
| Koukalová, R | 1 |
| Neuman, C | 1 |
1 review available for thalidomide and Angiomatosis
| Article | Year |
|---|---|
[Successful treatment of angiomatosis with thalidomide and interferon alpha. A description of five cases and overview of treatment of angiomatosis and proliferating hemangiomas].
Topics: Adult; Aged; Angiogenesis Inhibitors; Angiomatosis; Female; Hemangioma; Humans; Interferon-alpha; Ma | 2010 |
2 other studies available for thalidomide and Angiomatosis
| Article | Year |
|---|---|
[Treatment of multiple angiomatosis involving the skeleton and the abdominal and thoracic cavities with interferon alpha, thalidomide and zoledronate].
Topics: Adult; Angiogenesis Inhibitors; Angiomatosis; Diagnosis, Differential; Diphosphonates; Drug Therapy, | 2008 |
[Chronic disseminated intravascular coagulation (DIC) markers in a patient with multiple angiomatosis during treatment with anti-angiogenics: interferon α, thalidomide and lenalidomide].
Topics: Adult; Angiogenesis Inhibitors; Angiomatosis; Biomarkers; Disseminated Intravascular Coagulation; Hu | 2012 |